CoStar Group took the sharpest hit in today's analyst activity. The real estate data firm was downgraded by the consensus. The average target price fell to $38.89 from $44.05. That is an 11.7% cut. Short interest sits at just under 4% of free float. Bears already have a modest presence.
IQVIA Holdings moved the other way. Analysts pushed the average target to $266.74 from $252.58. That is a $14 upgrade. The clinical research firm has a $35.6bn market cap. With 18 buy ratings and no sells on record, the street is firmly bullish.
Teradyne also saw its target lifted. The chip-testing equipment maker now carries a consensus target of $443.20. Market cap has climbed past $52bn. Teradyne sits in semiconductor testing, a sector benefiting from AI-driven chip demand.
Coca-Cola received a notable target bump too. The consensus average rose to $93.57 from $90.43. That is a 3.5% increase. The move follows the company's recent earnings beat.
Incyte gained ground with analysts raising targets to $121.73 from $118.50. The biotech has 13 hold ratings. The upgrade implies expectations of pipeline progress ahead.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
